These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32463748)

  • 61. The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.
    Afghahi A; Kurian AW
    Curr Treat Options Oncol; 2017 May; 18(5):27. PubMed ID: 28439798
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
    Lheureux S; Karakasis K; Harter P; Scott C; Bacon M; Bryce J; Le Fur N; Pujade-Lauraine E; Oza AM
    Gynecol Oncol; 2016 Jan; 140(1):90-4. PubMed ID: 26475959
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Roll-out of an educational workshop to improve knowledge and self-confidence of healthcare professionals engaged in mainstreaming of breast cancer genetics.
    Jenkins V; Habibi R; Hall V; Leonard P; Lawn A; Naik J; Papps-Williams R; Fallowfield L
    PLoS One; 2024; 19(7):e0307301. PubMed ID: 39028724
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The frequency and outcome of breast cancer risk-reducing surgery in Finnish BRCA1 and BRCA2 mutation carriers.
    Koskenvuo L; Svarvar C; Suominen S; Aittomäki K; Jahkola T
    Scand J Surg; 2014 Mar; 103(1):34-40. PubMed ID: 24177987
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Setting up a nurse-led bowel 'two week wait' service.
    Bromley R; Cock K
    Br J Nurs; 2019 Sep; 28(16):1063-1068. PubMed ID: 31518538
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
    Zayas-Villanueva OA; Campos-Acevedo LD; Lugo-Trampe JJ; Hernández-Barajas D; González-Guerrero JF; Noriega-Iriondo MF; Ramírez-Sánchez IA; Martínez-de-Villarreal LE
    BMC Cancer; 2019 Jul; 19(1):722. PubMed ID: 31331294
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
    JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Service Delivery Model and Experiences in a Cancer Genetics Clinic for an Underserved Population.
    Woodson AH; Profato JL; Park M; Rizvi SH; Elsayegh N; Rieber AG; Arun BK
    J Health Care Poor Underserved; 2015 Aug; 26(3):784-91. PubMed ID: 26320913
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
    Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
    JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The first Japanese nationwide multicenter study of
    Enomoto T; Aoki D; Hattori K; Jinushi M; Kigawa J; Takeshima N; Tsuda H; Watanabe Y; Yoshihara K; Sugiyama T
    Int J Gynecol Cancer; 2019 Jul; 29(6):1043-1049. PubMed ID: 31263023
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Racial/Ethnic Disparities in BRCA Counseling and Testing: a Narrative Review.
    Williams CD; Bullard AJ; O'Leary M; Thomas R; Redding TS; Goldstein K
    J Racial Ethn Health Disparities; 2019 Jun; 6(3):570-583. PubMed ID: 30963508
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Finding all BRCA pathogenic mutation carriers: best practice models.
    Hoogerbrugge N; Jongmans MC
    Eur J Hum Genet; 2016 Sep; 24 Suppl 1(Suppl 1):S19-26. PubMed ID: 27514840
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
    Frey MK; Kopparam RV; Ni Zhou Z; Fields JC; Buskwofie A; Carlson AD; Caputo T; Holcomb K; Chapman-Davis E
    Cancer; 2019 Mar; 125(5):690-697. PubMed ID: 30480775
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Counseling the at risk patient in the BRCA1 and BRCA2 Era.
    Barnes-Kedar IM; Plon SE
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):341-66, vii. PubMed ID: 12108833
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A new scoring system in cancer genetics: application to criteria for BRCA1 and BRCA2 mutation screening.
    Bonaïti B; Alarcon F; Andrieu N; Bonadona V; Dondon MG; Pennec S; Stoppa-Lyonnet D; Bonaïti-Pellié C; Perdry H
    J Med Genet; 2014 Feb; 51(2):114-21. PubMed ID: 24343917
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A qualitative study on decision-making about BRCA1/2 testing in Italian women.
    Battistuzzi L; Franiuk M; Kasparian N; Rania N; Migliorini L; Varesco L
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13083. PubMed ID: 31056822
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Web-based return of BRCA2 research results: one-year genetic counselling experience in Iceland.
    Stefansdottir V; Thorolfsdottir E; Hognason HB; Patch C; van El C; Hentze S; Cordier C; Mendes Á; Jonsson JJ
    Eur J Hum Genet; 2020 Dec; 28(12):1656-1661. PubMed ID: 32523053
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A commentary on population genetic testing for primary prevention: changing landscape and the need to change paradigm.
    Manchanda R; Gaba F
    BJOG; 2019 May; 126(6):686-689. PubMed ID: 30770625
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.
    Butrick M; Kelly S; Peshkin BN; Luta G; Nusbaum R; Hooker GW; Graves K; Feeley L; Isaacs C; Valdimarsdottir HB; Jandorf L; DeMarco T; Wood M; McKinnon W; Garber J; McCormick SR; Schwartz MD
    Genet Med; 2015 Jun; 17(6):467-75. PubMed ID: 25232856
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.